Olivier Danos, Chief Scientific Officer at REGENXBIO Inc. (RGNX), sold 2,000 shares at $52.23 ($105K) on 2019-04-15, disclosed to the SEC on 2019-04-17.
Open-market sale of $105k RGNX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.23 | 1,000 | $52K | 49.6% |
| 2 | $53.09 | 1,000 | $53K | 50.4% |
| Total | $52.66 avg | 2,000 | $105K | 100% |